Literature DB >> 32814367

Enhancing organophosphate hydrolase efficacy via protein engineering and immobilization strategies.

Priya Katyal1, Stanley Chu1, Jin Kim Montclare1,2,3,4.   

Abstract

Organophosphorus compounds (OPs), developed as pesticides and chemical warfare agents, are extremely toxic chemicals that pose a public health risk. Of the different detoxification strategies, organophosphate-hydrolyzing enzymes have attracted much attention, providing a potential route for detoxifying those exposed to OPs. Phosphotriesterase (PTE), also known as organophosphate hydrolase (OPH), is one such enzyme that has been extensively studied as a catalytic bioscavenger. In this review, we will discuss the protein engineering of PTE aimed toward improving the activity and stability of the enzyme. In order to make enzyme utilization in OP detoxification more favorable, enzyme immobilization provides an effective means to increase enzyme activity and stability. Here, we present several such strategies that enhance the storage and operational stability of PTE/OPH.
© 2020 New York Academy of Sciences.

Entities:  

Keywords:  chemical warfare agents; organophosphate hydrolase; organophosphates; organophosphorus compounds; pesticides; phosphotriesterase

Year:  2020        PMID: 32814367      PMCID: PMC7771632          DOI: 10.1111/nyas.14451

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  91 in total

Review 1.  A review of nerve agent exposure for the critical care physician.

Authors:  Jerrold B Leikin; Richard G Thomas; Frank G Walter; Raymond Klein; Harvey W Meislin
Journal:  Crit Care Med       Date:  2002-10       Impact factor: 7.598

2.  Functional analysis of organophosphorus hydrolase variants with high degradation activity towards organophosphate pesticides.

Authors:  Catherine Mee-Hie Cho; Ashok Mulchandani; Wilfred Chen
Journal:  Protein Eng Des Sel       Date:  2006-01-19       Impact factor: 1.650

3.  Dramatically stabilized phosphotriesterase-polymers for nerve agent degradation.

Authors:  K E LeJeune; A J Mesiano; S B Bower; J K Grimsley; J R Wild; A J Russell
Journal:  Biotechnol Bioeng       Date:  1997-04-20       Impact factor: 4.530

4.  Immobilization of organophosphate hydrolase on biocompatible gelatin pads and its use in removal of organophosphate compounds and nerve agents.

Authors:  Anantha KoteswaraRao Kanugula; Elisha Raju Repalle; Jay Prakash Pandey; Gunwar Sripad; Chanchal Kumar Mitra; Devender Kumar Dubey; Dayananda Siddavattam
Journal:  Indian J Biochem Biophys       Date:  2011-02       Impact factor: 1.918

5.  (CdSe)ZnS quantum dots and organophosphorus hydrolase bioconjugate as biosensors for detection of paraoxon.

Authors:  Xiaojun Ji; Jiayin Zheng; Jianmin Xu; Vipin K Rastogi; Tu-Chen Cheng; Joseph J DeFrank; Roger M Leblanc
Journal:  J Phys Chem B       Date:  2005-03-10       Impact factor: 2.991

6.  Stereoselective hydrolysis of organophosphate nerve agents by the bacterial phosphotriesterase.

Authors:  Ping-Chuan Tsai; Andrew Bigley; Yingchun Li; Eman Ghanem; C Linn Cadieux; Shane A Kasten; Tony E Reeves; Douglas M Cerasoli; Frank M Raushel
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

7.  Preparation and application of cyclodextrin immobilized polysaccharides.

Authors:  Ji Sheng Yang; Li Yang
Journal:  J Mater Chem B       Date:  2012-12-12       Impact factor: 6.331

8.  Oximes in organophosphate poisoning: 60 years of hope and despair.

Authors:  Franz Worek; Horst Thiermann; Timo Wille
Journal:  Chem Biol Interact       Date:  2016-04-25       Impact factor: 5.192

9.  Engineering and introduction of de novo disulphide bridges in organophosphorus hydrolase enzyme for thermostability improvement.

Authors:  Gholamreza Farnoosh; Khosro Khajeh; Ali Mohammad Latifi; Hossein Aghamollaei
Journal:  J Biosci       Date:  2016-12       Impact factor: 1.826

10.  Automated Design of Efficient and Functionally Diverse Enzyme Repertoires.

Authors:  Olga Khersonsky; Rosalie Lipsh; Ziv Avizemer; Yacov Ashani; Moshe Goldsmith; Haim Leader; Orly Dym; Shelly Rogotner; Devin L Trudeau; Jaime Prilusky; Pep Amengual-Rigo; Victor Guallar; Dan S Tawfik; Sarel J Fleishman
Journal:  Mol Cell       Date:  2018-09-27       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.